Vaccines, Blood & Biologics

CliniMACS CD34 Reagent System

HDE Number:  BH110018
Device Name:  CliniMACS® CD34 Reagent System
Manufacturer: Miltenyi Biotech, Inc.
Indication: 

  •  The CliniMACS® CD34 Reagent System is indicated for processing hematopoietic progenitor cells collected by apheresis (HPC, Apheresis) from an allogeneic, HLA-identical, sibling donor to obtain a CD34+ cell-enriched population for hematopoietic reconstitution following a myeloablative preparative regimen without the need for additional graft versus host disease (GVHD) prophylaxis in patients with acute myeloid leukemia (AML) in first morphologic complete remission. 

 

Page Last Updated: 04/03/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.